Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Beijing Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 49 active clinical trials for multiple myeloma hosted across 27 tertiary medical centers in Beijing (including Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Chao-Yang Hospital, Capital Medical University, Peking University First Hospital, etc.).
Participating Medical Centers (27)
Active Studies in Beijing (49)
Population synthesized by CMDNShowing 0 published English records of 49 registry trials.
All 49 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.
